biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Post by unclepiemanon Apr 23, 2014 7:29pm

217 Views

Post# 22484050

email to bioasis

So i finally got around to emailing and asking a few simple questions, not that its going to change anything as most of the people on here have probably already tried contacting bioasis...

I've asked for a better explanation of:
- why the lack of communication with share holders
- AACR results / findings
- mice survival rate which were to have been originally released q4 2013

see what they have to say, if any...

Bullboard Posts

The top 10 Canadian medical stocks